Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

A Study For A New Vaccine Against Pneumococcal Disease

Please note: This trial has finished recruiting and is not accepting new participants.

Research Center: TrialsWest
Location: Suite 46, Level 2, St John of God Medical Clinic, 100 Murdoch Drive, Murdoch, WA
Lead Doctor: Dr. Peter Bremner
Ethics Committee: This study has been reviewed and approved by the Bellberry Human Research Ethics Committee.

This trial is sponsored by a pharmaceutical company.

Background

Pneumococcal disease is an infection caused by bacteria called Streptococcus pneumoniae. Each year, this disease causes thousands of infections, such as meningitis, bloodstream infections and pneumonia.

The good news is that pneumococcal vaccines can help prevent this disease.

Researchers seek to investigate the effectiveness of a new potential pneumococcal vaccine, comparing it to an already marketed vaccine. Eligible participants are male and female ages 50 years old and above. Volunteers are required to attend 2 study visits at the research site over approximately 6 months.

Why Participate? 

  • You will receive an investigational vaccination free of charge.
  • Information learned from the study may help other people in the future.
  • You will be helping to advance medical research.

Your Rights

  • If you decide to participate in the study and later feel that you no longer wish to be part of it, you may withdraw at any time.
  • Your records relating to this study and any other information received will be kept strictly confidential, except as required by law.
  • Qualified health professionals will monitor your health as it relates to the study.

Who Can Participate?

  • Men and women aged 50 and above
  • Females can not be pregnant
  • Able to attend 2 study visits at the research site over approximately  6 months
  • Has not had a vaccine for pneumococcal disease previously 

What Next?

  1. Click the link below to enter your contact details and answer some eligibility questions.
  2. The research centre will then contact you by phone to discuss the trial and answer your questions.
Click Here to Enter Your Contact Details and Be Contacted by Phone About the Trial

Is This Study Not For You?

Enter your details to be notified via email about new studies in your area

Is This Study Not For You?

Enter your details to be notified via email about new studies in your area

Gender(Required)